TrialBritish journal of clinical pharmacology2003

Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole.

Lynn Purkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.